Standout Papers

The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An Update 2016 2026 2019 2022 637
  1. The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An Update (2016)
    Mengchen Lu, Jianai Ji et al. Medicinal Research Reviews

Immediate Impact

2 by Nobel laureates 13 from Science/Nature 63 standout
Sub-graph 1 of 19

Citing Papers

Brain endothelial GSDMD activation mediates inflammatory BBB breakdown
2024 StandoutNature
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
2 intermediate papers

Works of Mengchen Lu being referenced

Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway
2018
The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
2016 Standout

Author Peers

Author Last Decade Papers Cites
Mengchen Lu 1751 383 104 236 42 2.3k
Leilei Fu 1622 190 92 382 56 2.7k
Hüveyda Başağa 1174 195 98 229 62 2.4k
Josep J. Centelles 1361 205 74 300 83 2.6k
Konjeti R. Sekhar 2225 294 63 284 65 3.2k
Montserrat Rojo de la Vega 2728 248 83 278 36 3.7k
Margareta Berggren 1785 280 27 272 38 2.5k
Qian Lei 1029 303 80 238 83 1.9k
Odile Sergent 1379 236 75 255 67 2.9k
Michael Danilenko 1950 430 33 249 70 3.4k
Bob G. Sanders 1912 549 71 333 111 3.3k

All Works

Loading papers...

Rankless by CCL
2026